A compact Cas12n enzyme that barely edited human cells in its natural form was redesigned with four charge-swapping mutations and a shorter guide scaffold to become an efficient, delivery-friendly genome editor.
A structure-guided electrostatic redesign produced a quadruple mutant (v4.6) of CgCas12n with up to ~60-fold higher reporter activity than wild-type and high indel rates at endogenous targets.
Introducing four arginines near the crRNA–DNA duplex (D157R, Q170R, T184R, T423R) likely stabilizes the negatively charged heteroduplex and improves editing across multiple human cell lines.
Rational trimming of the single-guide RNA yielded a compact scaffold variant (D19) that kept ~92% of activity while removing 38 base pairs, improving suitability for vector delivery.
# What changed and why it matters Researchers took CgCas12n — a 537–amino-acid type V-U4 CRISPR nuclease that previously showed essentially no editing in mammalian cells — and used structure-guided engineering to transform it into a high-performance genome editor. They combined targeted amino-acid substitutions intended to increase local positive charge with systematic guide-RNA trimming. The result: a quadruple mutant named v4.6 that showed large gains in reporter assays and produced robust indel frequencies at endogenous human loci.
# How the engineering strategy worked The team focused on electrostatics around the crRNA–target DNA heteroduplex, a negatively charged structure inside the active complex. They compared CgCas12n sequences with active relatives (AsCas12a and AcCas12n) and identified 52 candidate single-site substitutions where CgCas12n had neutral or negative residues while the active proteins had positively charged residues.
Screening in HEK293T cells used a fluorescence reporter where nuclease cleavage restores an out-of-frame EGFP. Eleven single substitutions improved activity (1.2- to 5.2-fold gains). Combining beneficial substitutions produced double, triple, and quadruple mutants. The standout v4.6 carries D157R, Q170R, T184R, and T423R and exceeded 20% editing in the reporter assay — about a 60-fold improvement over wild-type CgCas12n.
AlphaFold2 structural models placed all four introduced arginines close to the crRNA–DNA duplex, supporting the hypothesis that added positive charge stabilizes the nucleic-acid interaction and boosts activity.
# Performance at genomic targets and in other cell lines At endogenous loci with a 5′-AAG PAM in HEK293T cells, the v4.6 variant produced indel frequencies of 58.7% and 71.4% at two tested sites. The engineered enzyme showed comparable activity in HeLa and K562 cells, indicating the improvements generalize beyond the initial reporter assay.
# Guide RNA redesign to reduce size
# Why compact Cas12n matters for delivery and targeting Large editors like SpCas9 often exceed adeno-associated virus (AAV) vector capacity when combined with guides and regulatory elements. Compact nucleases such as Cas12n (400–700 amino acids across the family) can fit into tight delivery formats. Cas12n enzymes are also presumed to act as monomers and prefer A-rich PAM sequences, which lets them target sites that G-rich or T-rich PAM-restricted editors cannot.
# Practical takeaway for researchers If you need a small, delivery-friendly editor that can target A-rich PAMs, the engineered CgCas12n v4.6 plus the D19 guide scaffold is a candidate worth testing. The engineering path shown here — identify charge differences near the RNA–DNA duplex, screen single substitutions, combine beneficial mutations, and trim the guide scaffold selectively — provides a reproducible workflow for rescuing underperforming miniature CRISPR systems.
# What remains to check The report documents strong improvements in cultured human cell lines and structure-guided rationale, but downstream steps for any application should include independent specificity profiling, off-target assessment, delivery optimization in the chosen vector, and evaluation in relevant primary cells or in vivo models before therapeutic use.
Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR and may be even more effective.
A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations, potentially enabling mutation-agnostic gene therapies for diverse genetic diseases with fewer individualized edits. The post Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration
A CRISPR-based method for disrupting genes across bacteriophage genomes has been developed, creating a faster route to uncover gene functions and engineer phages for potential therapeutic and biotechnology applications. The post New CRISPR-Based Tool Enables Genome-Wide Mutagenesis of Bacteriophages appeared first on G
CRISPR may be a powerful technology for gene editing, but the system existed in bacteria long before scientists began using it. For billions of years, CRISPR has acted as a natural immune system in bacteria and other microbes, helping defend them against invading viruses. But now, two new studies, published in Science,
CRISPR-Cas9 has transformed the life sciences by giving researchers a seemingly simple tool for cutting DNA at chosen locations, but a new study published in Genome Medicine delivers a sobering reminder that the aftermath of those cuts is far messier than standard screening methods suggest. A team led by Ida Höijer and
Pepper is one of the most economically important vegetable crops in the world, yet scientists trying to understand which of its genes do what have long been hampered by a stubborn technical bottleneck. Stable genetic transformation of pepper, the gold standard for confirming gene function, is notoriously slow and ineff
Loading more related stories...
Open the app view to save this story, compare related coverage, and continue from the same source.